Atrioventricular septal defect cardiac catheterization: Difference between revisions
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class II a]]=== | ===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class II a]]=== | ||
1. Cardiac catheterization is reasonable to assess PAH and test vasoreactivity in patients with repaired or unrepaired AVSD. (Level of Evidence: B) | 1. Cardiac catheterization is reasonable to assess PAH and test vasoreactivity in patients with repaired or unrepaired AVSD. (Level of Evidence: B)}} | ||
==References== | ==References== | ||
Revision as of 15:00, 1 October 2012
|
Atrioventricular septal defect Microchapters |
|
Differentiating Atrioventricular septal defect from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Atrioventricular septal defect cardiac catheterization On the Web |
|
American Roentgen Ray Society Images of Atrioventricular septal defect cardiac catheterization |
|
FDA on Atrioventricular septal defect cardiac catheterization |
|
CDC on Atrioventricular septal defect cardiac catheterization |
|
Atrioventricular septal defect cardiac catheterization in the news |
|
Blogs on Atrioventricular septal defect cardiac catheterization |
|
Risk calculators and risk factors for Atrioventricular septal defect cardiac catheterization |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cardiac Catheterization
ACC / AHA Guidelines- Recommendation for Heart Catheterization (DO NOT EDIT)
| “ |
Class II a1. Cardiac catheterization is reasonable to assess PAH and test vasoreactivity in patients with repaired or unrepaired AVSD. (Level of Evidence: B) |
” |